Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888812514> ?p ?o ?g. }
- W2888812514 endingPage "134" @default.
- W2888812514 startingPage "1" @default.
- W2888812514 abstract "Background Traumatic brain injury (TBI) is a major cause of disability and death in young adults worldwide. It results in around 1 million hospital admissions annually in the European Union (EU), causes a majority of the 50,000 deaths from road traffic accidents and leaves a further ≈10,000 people severely disabled. Objective The Eurotherm3235 Trial was a pragmatic trial examining the effectiveness of hypothermia (32–35 °C) to reduce raised intracranial pressure (ICP) following severe TBI and reduce morbidity and mortality 6 months after TBI. Design An international, multicentre, randomised controlled trial. Setting Specialist neurological critical care units. Participants We included adult participants following TBI. Eligible patients had ICP monitoring in place with an ICP of > 20 mmHg despite first-line treatments. Participants were randomised to receive standard care with the addition of hypothermia (32–35 °C) or standard care alone. Online randomisation and the use of an electronic case report form (CRF) ensured concealment of random treatment allocation. It was not possible to blind local investigators to allocation as it was obvious which participants were receiving hypothermia. We collected information on how well the participant had recovered 6 months after injury. This information was provided either by the participant themself (if they were able) and/or a person close to them by completing the Glasgow Outcome Scale – Extended (GOSE) questionnaire. Telephone follow-up was carried out by a blinded independent clinician. Interventions The primary intervention to reduce ICP in the hypothermia group after randomisation was induction of hypothermia. Core temperature was initially reduced to 35 °C and decreased incrementally to a lower limit of 32 °C if necessary to maintain ICP at < 20 mmHg. Rewarming began after 48 hours if ICP remained controlled. Participants in the standard-care group received usual care at that centre, but without hypothermia. Main outcome measures The primary outcome measure was the GOSE [range 1 (dead) to 8 (upper good recovery)] at 6 months after the injury as assessed by an independent collaborator, blind to the intervention. A priori subgroup analysis tested the relationship between minimisation factors including being aged < 45 years, having a post-resuscitation Glasgow Coma Scale (GCS) motor score of < 2 on admission, having a time from injury of < 12 hours and patient outcome. Results We enrolled 387 patients from 47 centres in 18 countries. The trial was closed to recruitment following concerns raised by the Data and Safety Monitoring Committee in October 2014. On an intention-to-treat basis, 195 participants were randomised to hypothermia treatment and 192 to standard care. Regarding participant outcome, there was a higher mortality rate and poorer functional recovery at 6 months in the hypothermia group. The adjusted common odds ratio (OR) for the primary statistical analysis of the GOSE was 1.54 [95% confidence interval (CI) 1.03 to 2.31]; when the GOSE was dichotomised the OR was 1.74 (95% CI 1.09 to 2.77). Both results favoured standard care alone. In this pragmatic study, we did not collect data on adverse events. Data on serious adverse events (SAEs) were collected but were subject to reporting bias, with most SAEs being reported in the hypothermia group. Conclusions In participants following TBI and with an ICP of > 20 mmHg, titrated therapeutic hypothermia successfully reduced ICP but led to a higher mortality rate and worse functional outcome. Limitations Inability to blind treatment allocation as it was obvious which participants were randomised to the hypothermia group; there was biased recording of SAEs in the hypothermia group. We now believe that more adequately powered clinical trials of common therapies used to reduce ICP, such as hypertonic therapy, barbiturates and hyperventilation, are required to assess their potential benefits and risks to patients. Trial registration Current Controlled Trials ISRCTN34555414. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment ; Vol. 22, No. 45. See the NIHR Journals Library website for further project information. The European Society of Intensive Care Medicine supported the pilot phase of this trial." @default.
- W2888812514 created "2018-09-07" @default.
- W2888812514 creator A5005345827 @default.
- W2888812514 creator A5007401350 @default.
- W2888812514 creator A5024244103 @default.
- W2888812514 creator A5045495567 @default.
- W2888812514 creator A5060534192 @default.
- W2888812514 creator A5086588818 @default.
- W2888812514 creator A5090576828 @default.
- W2888812514 date "2018-08-01" @default.
- W2888812514 modified "2023-09-29" @default.
- W2888812514 title "Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT" @default.
- W2888812514 cites W137337681 @default.
- W2888812514 cites W147204252 @default.
- W2888812514 cites W1498265361 @default.
- W2888812514 cites W1511468068 @default.
- W2888812514 cites W1518136043 @default.
- W2888812514 cites W1525389838 @default.
- W2888812514 cites W1589350557 @default.
- W2888812514 cites W1629711306 @default.
- W2888812514 cites W1740670580 @default.
- W2888812514 cites W1759438376 @default.
- W2888812514 cites W19428414 @default.
- W2888812514 cites W1964528050 @default.
- W2888812514 cites W1965033437 @default.
- W2888812514 cites W1965462309 @default.
- W2888812514 cites W1965747189 @default.
- W2888812514 cites W1970068852 @default.
- W2888812514 cites W1972367009 @default.
- W2888812514 cites W1973406593 @default.
- W2888812514 cites W1975131252 @default.
- W2888812514 cites W1976281868 @default.
- W2888812514 cites W1980509004 @default.
- W2888812514 cites W1981082943 @default.
- W2888812514 cites W1982049901 @default.
- W2888812514 cites W1982835830 @default.
- W2888812514 cites W1985323628 @default.
- W2888812514 cites W1985857822 @default.
- W2888812514 cites W1987020838 @default.
- W2888812514 cites W1987042677 @default.
- W2888812514 cites W1988128504 @default.
- W2888812514 cites W1989684538 @default.
- W2888812514 cites W1989837412 @default.
- W2888812514 cites W1989883289 @default.
- W2888812514 cites W1993769799 @default.
- W2888812514 cites W1995826793 @default.
- W2888812514 cites W2001515223 @default.
- W2888812514 cites W2002843252 @default.
- W2888812514 cites W2004220886 @default.
- W2888812514 cites W2005292744 @default.
- W2888812514 cites W2005436138 @default.
- W2888812514 cites W2009582227 @default.
- W2888812514 cites W2012759278 @default.
- W2888812514 cites W2013256551 @default.
- W2888812514 cites W2013335042 @default.
- W2888812514 cites W2013387874 @default.
- W2888812514 cites W2013922867 @default.
- W2888812514 cites W2016453860 @default.
- W2888812514 cites W2020764769 @default.
- W2888812514 cites W2022201528 @default.
- W2888812514 cites W2024808825 @default.
- W2888812514 cites W2027737333 @default.
- W2888812514 cites W2031003242 @default.
- W2888812514 cites W2034011023 @default.
- W2888812514 cites W2038252730 @default.
- W2888812514 cites W2042703144 @default.
- W2888812514 cites W2043796451 @default.
- W2888812514 cites W2044904834 @default.
- W2888812514 cites W2045834816 @default.
- W2888812514 cites W2046083894 @default.
- W2888812514 cites W2046934316 @default.
- W2888812514 cites W2047387664 @default.
- W2888812514 cites W2049481900 @default.
- W2888812514 cites W2053224120 @default.
- W2888812514 cites W2057560001 @default.
- W2888812514 cites W2058701241 @default.
- W2888812514 cites W2062642814 @default.
- W2888812514 cites W2066421951 @default.
- W2888812514 cites W2068904022 @default.
- W2888812514 cites W2070921889 @default.
- W2888812514 cites W2071002396 @default.
- W2888812514 cites W2071038474 @default.
- W2888812514 cites W2071819764 @default.
- W2888812514 cites W2077017039 @default.
- W2888812514 cites W2078568251 @default.
- W2888812514 cites W2079309743 @default.
- W2888812514 cites W2087599304 @default.
- W2888812514 cites W2088336119 @default.
- W2888812514 cites W2091566600 @default.
- W2888812514 cites W2099514701 @default.
- W2888812514 cites W2103324713 @default.
- W2888812514 cites W2104846265 @default.
- W2888812514 cites W2104869294 @default.
- W2888812514 cites W2107456086 @default.
- W2888812514 cites W2112517536 @default.
- W2888812514 cites W2114488753 @default.
- W2888812514 cites W2114972155 @default.
- W2888812514 cites W2121462621 @default.